Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

3 factors that lead to missed injuries in multi-trauma CT patients

In patients with multiple traumas, those who were over 30 years old with severe injuries across more than two body parts were more likely to experience a missed injury upon initial CT scan, according to a recent Radiology study.

Thumbnail

1-month post-RT imaging unnecessary for liver cancer patients

“Treatment effect is more reliably determined on imaging at 90 days following SIRT, however imaging at one-month post-SIRT is still frequently performed,” Shamar Young, MD, and colleagues wrote. “This raises the question as to whether or not imaging at one month following SIRT is clinically warranted.”

Thumbnail

Amount, location, size of brain lesions can determine advancement to MS

Identifying the amount, location and size of lesions on MRI can predict the risk of progression from an early stage of multiple sclerosis (MS) to an official diagnosis within a year, according to authors of a new Brain and Behavior study.

Thumbnail

USPSTF: Insufficient evidence to support AFib screening with ECG

The U.S. Preventive Task Force (USPSTF) issued a Grade I recommendation, indicating there is insufficient evidence assessing the benefits and harms of screening for atrial fibrillation (AFib) with electrocardiography (ECG) in patients 65 and older with previously undiagnosed AFib.

Konica Minolta Healthcare Announces the UGPro Solution, a New Initiative Providing Complete Solutions for Ultrasound Guided Procedures

Konica Minolta Healthcare Americas, Inc., a leader in MSK Ultrasound, announces UGPro™ Solution, a new initiative that provides complete solutions for ultrasound guided procedures (UGP) and therapies.

Thumbnail

PET imaging method could improve Type 1 diabetes treatment

Yale University researchers have discovered a new PET imaging method that measures beta-cell mass which could improve monitoring, according to research published online in the August issue of the Journal of Nuclear Medicine.  

Thumbnail

PET tracer IDs estrogen receptor variation in breast cancer patients

Dutch researchers utilized a PET tracer to distinguish differences in estrogen receptor (ER) expression in metastatic breast cancer patients, according to a recent Journal of Nuclear Medicine study. Findings may enhance treatment for these patients.

Thumbnail

Cardiac monitoring may protect high-risk breast cancer patients against heart failure

While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of the American College of Cardiology notes individuals treated with trastuzumab-based chemotherapy have a higher risk for HF—but they are not monitored for it, despite recommendations.